What It MeasuresActive-chromatin cfDNA others discard What It EnablesPrevention through drug development Supporting EvidenceThe published record behind the platform

Rheumatoid ArthritisA therapy selection test in clinical validation Platform in action

Every program here runs on the same active-chromatin cfDNA platform.

See how it works

Spotlight · RA testing

A blood-based test to inform treatment selection.

Most RA patients cycle through therapies before finding one that works. Aqtual's blood test reads synovial-associated active-chromatin signal to help match each patient to the right treatment class from the start.

1

Blood draw

70%+

Don't respond to first-line TNFi adequately

PRIMA-102

Clinical validation study

Explore the RA test

Platform DataTissue-level readouts from a single blood draw Functional Disease AtlasesDisease biology mapped onto blood signal Biospecimen ServicesAnnotated specimens procured end to end

MissionWhy we're building this Meet the TeamVeteran diagnostics leaders GalleryInside our Hayward facility

Press ReleasesOfficial company announcements ConferencesWhere to find us next

Contact

Contact Aqtual

Leave us a message and a team member will get back to you within 24 hours during our business hours, Monday through Friday, 9:00 AM to 5:00 PM Pacific Time.

Get in touch

Contact Aqtual.

Platform

Full nameincomplete
Work emailincomplete
Your messageincomplete

media@aqtual.com
341-208-8569
31145 San Antonio St. Hayward, CA, 94544

Visit

Headquarters

31145 San Antonio St.
Hayward, CA 94544

Response hours

Within 24 hours, Monday through Friday, 9:00 AM to 5:00 PM Pacific Time.